🔎 Trials Near Me

Hem › Hemofili › Pennsylvania

Kliniska studier för Hemofili i Pennsylvania

6 studier för Hemofili söker deltagare vid platser i Pennsylvania.

Städer i Pennsylvania

Officiell studietext (engelska)

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

  • The Childrens Hospital of Philadelphia Division of Hematology, Philadelphia
  • The Childrens Hospital of Philadelphia Division of Hematology, Philadelphia
RekryterarFas 3
Ålder 18 och äldre · Män · Uppdaterad 2 okt. 2026 · NCT05568719

A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A

  • Penn State MS Hershey Med Ctr, Hershey
  • St Christopher Hosp for Child, Philadelphia
RekryterarFas 1Friska volontärer välkomna
Ålder 18 till 64 · Män · Uppdaterad 18 sep. 2026 · NCT07220564

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Children's Hospital of Philadelphia, Philadelphia
  • Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania, Philadelphia
  • St. Christopher's Hospital for Children, Philadelphia
  • och 1 fler
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 17 aug. 2026 · NCT04398628

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

  • Penn State Milton S Hershey Medical Center Pediatrics, Hershey
  • Perelman Center for Advanced Medicine (PCAM)- Penn Blood Disorders Program, Philadelphia
RekryterarFas 1Friska volontärer välkomna
Ålder 18 till 60 · Alla kön · Uppdaterad 2 juli 2026 · NCT06349473

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

  • The Feinstein Institutes for Medical Research, Philadelphia
RekryterarFas 3
Ålder 1 till 74 · Män · Uppdaterad 1 juli 2026 · NCT05145127

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

  • Penn State College of Medicine, Hershey
RekryterarFas 1
Ålder 0 till 90 · Alla kön · Uppdaterad 3 apr. 2026 · NCT05500807

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.